Walsh & Hoyt: Sildenafil

Update Item Information
Identifier wh_ch10_p457_1
Title Walsh & Hoyt: Sildenafil
Creator Paul H. Phillips, MD
Affiliation University of Arkansas
Subject Optic Nerve Diseases; Malnutrition; Toxicity; Optic Neuropathy; Sildenafil
Description Sildenafil citrate (Viagra, Pfizer Pharmaceuticals, New York, NY) is a phosphodiesterase type 5 inhibitor that is prescribed for erectile dysfunction. This drug facilitates erections by augmenting nitric oxide induced vasodilation in the corpus cavernosum. Systemic side effects are related to drug induced systemic vasodilation and include headache, flushing, and systemic hypotension. Severe systemic hypotension may occur when sildenafil is ingested with other nitrate medications. The most common ocular side effect is a transient alteration of color perception that presumably occurs from sildenafils weak inhibitory effect on phosphodiesterase type 6, a phototransduction enzyme present in the retinal photoreceptor outer segments.
Date 2005
Language eng
Format application/pdf
Type Text
Source Walsh and Hoyt's Clinical Neuro-Ophthalmology, 6th Edition
Relation is Part of Walsh and Hoyt's Clinical Neuro-Ophthalmology Walsh and Hoyt's Clinical Neuro-Ophthalmology
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Wolters Kluwer Health, Philadelphia
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah, 10 N 1900 E SLC, UT 84112-5890
Rights Management Copyright 2005. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6p01h5j
Setname ehsl_novel_whts
ID 186350
Reference URL https://collections.lib.utah.edu/ark:/87278/s6p01h5j
Back to Search Results